Perbedaan Kentanix Supra International Tbk. dan Merck Tbk.: Kentanix Supra International Tbk. diperdagangkan di Rp280 (kapitalisasi pasar 594,32 M, volume 24 jam 17 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar Kentanix Supra International Tbk., dan Merck Tbk. lebih aktif diperdagangkan (37,6 rb vs 17 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KSIX | MERK | |
|---|---|---|
Kapitalisasi Pasar | 594,32 M | 1,7 T |
Volume | 17 rb | 37,6 rb |
Lot | 170 | 376 |
Perputaran | 4,73 jt | 144,47 jt |
Harga Rata-rata | 278,14 | 3.842,23 |
Nilai Transaksi | 4,73 jt | 144,47 jt |
Harga Ekuilibrium Indikatif | 278 | 3.840 |
Volume Ekuilibrium Indikatif | 500 | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Selengkapnya di halaman KSIX →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →